TrialCell reports. Medicine2025

Effect of henagliflozin on aging biomarkers in patients with type 2 diabetes: A multicenter, randomized, double-blind, placebo-controlled study.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.